What Happened?
San Diego, CA-based Marie-Claire Durkin as Senior Manager of Operations
About the Company
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
About the Person
Marie-Claire Durkin is a highly motivated operations professional with over 15 year experience in the biotech/pharmaceutical industry with the ability to tackle multiple responsibilities while working independently in a fast paced environment. She has broad experience in cross-functional roles including project management, accounting oversight and management of support staff for both private and public companies.
Info Source
Press Release
Short Profile